Tumors were harvested, mechanically cut into small pieces, and then enzymatically treated with 1 mg/mL collagenase D (IV type, Clostridium histolyticum, Sigma) and 0.02 mg/mL DNase I (from bovine pancreas grade 2, Roche) at 37 °C for 30 min. The enzymatic reaction was stopped by adding EDTA (Sigma). The ensuing single-cell suspension was filtered by means of a 70-µm cell strainer and prepared for cytofluorimetric analysis. After Fc blocking, single-cell suspensions were stained with the following antibodies from Miltenyi Biotec: CD45-VioGreen (clone: REA737); NK1.1-APC (clone: PK136); CD11b-Vioblue (clone: REA592); CD3-PE (clone: REA641); CD69-PEVio770 (clone: REA937); Ly6C-PE (clone: 1G7.G10); CD4-PEVio770 (clone: REA604); CD8-Vioblue (clone: 53.6.7); and F4/80-PercPVio700 (clone: REA126). Subsequently, cell viability was determined by LIVE/Dead-633 nm (L10120) staining according to the manufacturer’s instructions (Invitrogen); negative cells were considered viable. Doublet exclusion and gating on live CD45+ cells were performed. The following subpopulations of CD45+ were identified: CD11b+ Ly6C+ (monocytes), CD11b+ F4/80+ (macrophages), CD3+CD4+ and CD3+C8+ (T cells) and NK1.1+CD3 (NK cells). Cells were analyzed on a MACSQuant16 (Miltenyi) and analyzed with FlowJo software (RRID:SCR_008520, Treestar) [28 (link)].
Free full text: Click here